Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

Scynexis, Inc. · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
invasive candidiasis, mucocutaneous candidiasis, coccidioidomycosis, histoplasmosis, blastomycosis, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, invasive pulmonary aspergillosis, recurrent vulvovaginal candidiasis, other emerging fungi, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 910126
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.